Christine Rowley

Technical and Operations Director, UK 


Christine has over 16 years’ experience in the medical device biologics industry, joining Tissue Regenix in 2010. Since starting her career, she has worked in all areas of product development and commercialisation, and has lead the development of the OrthoPure XT device from product feasibility through to market approval and launch. Christine’s experience covers a wide range of activities, including new product development, process optimisation & design transfer, design verification & validation, clinical trial design & execution, regulatory submissions, and quality control, almost exclusively working with class III xenograft implants.

Christine has held leadership roles within the product development, regulatory, clinical and quality sectors, and has achieved market clearance of xenograft medical devices in multiple countries worldwide.

Christine has several patients associated with the decellularisation and manipulation of collagenous tissues for potential health care benefits. Christine has a Batchelor of Science degree in Biological Sciences from the University of Exeter (UK).